Principal Financial Group Inc 4 D Molecular Therapeutics, Inc. Transaction History

Principal Financial Group Inc

  • $1.66 Trillion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 29, 2024
BUY
$20.93 - $30.01 $38,699 - $55,488
1,849 Added 9.64%
21,034 $441,000
Q1 2024

Apr 29, 2024
BUY
$17.03 - $35.87 $156,744 - $330,147
9,204 Added 92.22%
19,185 $611,000
Q4 2023

Feb 07, 2024
SELL
$9.76 - $21.25 $10,345 - $22,525
-1,060 Reduced 9.6%
9,981 $202,000
Q3 2023

Nov 02, 2023
BUY
$12.64 - $19.76 $139,558 - $218,170
11,041 New
11,041 $140,000

Others Institutions Holding FDMT

# of Institutions
146
Shares Held
57M
Call Options Held
137K
Put Options Held
111K
View Full List

About 4D Molecular Therapeutics, Inc.

FDMT Quotes by TradingView
  • Ticker FDMT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 32,382,400
  • Market Cap $151M
  • Description
  • 4D Molecular Therapeutics, Inc., a clinical-stage gene therapy company, develops product candidates using its adeno-associated viruses vectors. It develops a portfolio of gene therapy product candidates focuses in three therapeutic areas: ophthalmology, cardiology, and pulmonology. The company has three product candidates that are in clinical tr...
More about FDMT
Track This Portfolio

Track Principal Financial Group Inc Portfolio

Follow Principal Financial Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Principal Financial Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email